Beyond antibodies: using biological principles to guide the development of next-generation protein therapeutics

- Biologics based on monoclonal antibodies have dominated the clinical landscape.
- New knowledge of disease mechanisms is driving current drug discovery efforts.
- Ligands and receptors provide unique opportunities to manage biological complexity.
- Protein engineering is generating therapeutics with improved safety and efficacy.